From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DoD Seeks Integrator for Vaccine Development Efforts

by Global Biodefense Staff
November 24, 2014
Biodefense Vaccine Development

Credit: Shutterstock, modified by Global Biodefense

The U.S. Department of Defense has issued a Request for Information (RFI) to survey industry on their interest as a prime systems integrator for DoD vaccine development efforts.

The effort is managed by the Medical Countermeasure Systems – Joint Vaccine Acquisition Program (MCS-JVAP), the life cycle manager for the Department of Defense (DoD) responsible for developing, producing and stockpiling FDA-licensed vaccines to protect the Warfighter from biological agents.

The contractor would be responsible for all facets of vaccine development including:

  • Development of nonclinical and clinical drug supply
  • Analytical methods development
  • Non-clinical IND enabling studies
  • Phase 1 clinical trials
  • Regulatory strategy to assure FDA-licensure
  • Delivering FDA-licensed vaccines to maintain DoD stockpiles

Further details are available under Solicitation Number: W911QY-15-RFI-VACCINE. The response deadline is January 30, 2015.

From Our Partners
Tags: RFIVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC